Addiction Medicine for Non-Specialists 2025

Overview

Online CME Focus: Substance Use Disorders

Addiction Medicine for Non-Specialists is a comprehensive video CME program geared toward clinicians who see patients with substance use disorders, whether substance use is the primary complaint or not. This collection of thorough and expertly informed lectures will help you more effectively screen, treat, refer, and follow up with these patients.

Led by Antoine Douaihy, MD, experienced practitioners address the need to integrate, prioritize, and personalize care while avoiding harmful stigmas and racial and ethnic disparities. Featured continuing medical education topics include:

• The Pharmacology of Substances of Use
• Gambling Disorders
• Technology Addiction
• Helping Family Members Affected by Substance Use Disorders
• Mindfulness-Based Treatment of Substance Use Disorders

Good to Know: This activity meets the Drug Enforcement Administration (DEA) and Substance Abuse and Mental Health Services Administration (SAMHSA) requirement that as of June 27, 2023, new or renewing DEA registrants must complete a minimum of 8 hours of accredited continuing education (CE) on the treatment and management of patients with opioid or other substance use disorders before renewing their license.

Topics / Speakers

Addiction – An Overview - Antoine Douaihy, MD

Neurobiological Aspects of Substance Use Disorder - Jody Glance, MD

The Epidemiology of Substance Use Disorders - Antoine Douaihy, MD

Screening, Evaluation, and Diagnosis of Substance Use Disorders - Antoine Douaihy, MD

The Pharmacology of Substances of Use - Sharon Connor, MD, and Cassandra Kruse, MD

Management of Intoxication, Withdrawal, and Perioperative Care in Individuals with Substance Use Disorders - Megha Patel, PharmD, BCPS

Alcohol Use Disorder - Julie Kmiec, DO

Stimulant Use Disorder (StUD) – Treatment Overview and Future Therapies - Thersilla Oberbarnscheidt, MD, PhD

Opioid Use Disorder - Julie Kmiec, DO

Benzodiazepine Use and Misuse - Tae Woo Park, MD

Cannabis Use Disorder - Thersilla Oberbarnscheidt, MD

Tobacco Use Disorder - Antoine Douaihy, MD

Chronic Pain and Substance Use Disorders - Amanda Price, MD

Acute Pain and Substance Use Disorder - Julie Wilson Childers, MD

Brief Interventions and Motivational Interviewing for Substance Use Disorders - Cassandra Boness, PhD

Helping Patients with Substance Use Disorders and Co-occurring Psychiatric Psychiatric Disorders (CODs) - Dennis Daley, PhD

The Use of Harm Reduction Strategies with Substance Use Disorders - David Loveland, PhD

Perinatal Substance Use Disorders - Jody Glance, MD

Pharmacotherapy for Adolescents with Substance Use Disorders - Duncan Clark, MD, PhD

Substance Use Disorders in Older Individuals - Katie F. Jones, MD

Healthcare and Racial Disparities in Addiction Treatment - Antoine Douaihy, MD

Medical Complications of Substance Use Disorders including HIV and HCV - Jordi Blanch, MD, PhD

Pain and Opioid Complexity in Individuals with Serious Illness - Varad Deshmukh, MD

The Rise of Gambling Disorder – Significance, Assessment, and Treatment in an Era of Exploding Access - Kavita Fischer, MD

Technology Addiction - Hector Colon-Rivera, MD

Helping Family Members Affected by Substance Use Disorders - Dennis Daley, PhD

Mindfulness-based Treatment of Substance Use Disorders - Antoine Douaihy, MD

Safe and Efficacious Prescribing for Chronic Pain - James R. Latronica, DO, DFASAM

Faculty

Course Director

Speakers

Accreditation

Oakstone Publishing is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation

American Medical Association (AMA)

Oakstone Publishing designates this enduring material for a maximum of 24.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

American Board of Internal Medicine (ABIM)

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 24.75 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Date of Original Release: April 30, 2025
Date Credits Expire: April 29, 2028
Estimated Time to Complete: 24.75 hours

CME credit is awarded upon successful completion of a course evaluation and post-test.

Learning Objectives

At the completion of this course, you should be able to:

• Summarize the three main stages of the addiction cycle
• List the signs and symptoms of alcohol withdrawal
• Discuss the epidemiology of opioid use disorder and the medical complications of this disorder
• Summarize the risk factors for benzodiazepine use disorder/misuse
• Explain the toxic effects of cannabis and CBD
• Recognize why and how pain and substance use disorder can co-occur
• Outline the management of acute pain in patients who are prescribed buprenorphine or methadone for opioid use disorder
• Describe culturally, racially, and ethnically informed healthcare
• Name the risk factors and special considerations for women with substance use disorder
• List the brief interventions skills found in OARS

Intended Audience

This educational activity was designed for internists, family physicians, psychiatrists, emergency physicians, PM&R physicians, and neurologists.

Quick Facts

Provider: Oakstone CME

Course Director:
Antoine Douaihy, MD

Professor of Psychiatry and Medicine

University of Pittsburgh School of Medicine

Senior Academic Director of

Addiction Medicine Services

UPMC Western Psychiatric Hospital

Pittsburgh, PA

Credits: Earn a maximum of 24.75 AMA PRA Category 1 Credits™ and 24.75 ABIM MOC points